These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33968041)

  • 21. Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.
    Sgadari C; Monini P; Tripiciano A; Picconi O; Casabianca A; Orlandi C; Moretti S; Francavilla V; Arancio A; Paniccia G; Campagna M; Bellino S; Meschiari M; Nozza S; Sighinolfi L; Latini A; Muscatello A; Saracino A; Di Pietro M; Galli M; Cafaro A; Magnani M; Ensoli F; Ensoli B
    Front Immunol; 2019; 10():233. PubMed ID: 30815001
    [No Abstract]   [Full Text] [Related]  

  • 22. Cell-to-Cell Spread of HIV and Viral Pathogenesis.
    Law KM; Satija N; Esposito AM; Chen BK
    Adv Virus Res; 2016; 95():43-85. PubMed ID: 27112280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of immune complexes and plasma viral load with CD4+ cell depletion, CD8+ DR+ and CD16+ cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4+ lymphocyte depletion.
    Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    Immunol Lett; 2001 Mar; 76(2):69-78. PubMed ID: 11274723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short communication: HIV antigen-specific reactivation of HIV infection from cellular reservoirs: implications in the settings of therapeutic vaccinations.
    Shete A; Thakar M; Singh DP; Gangakhedkar R; Gaikwad A; Pawar J; Paranjape R
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):835-43. PubMed ID: 21936714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy.
    Madhavi V; Ana-Sosa-Batiz FE; Jegaskanda S; Center RJ; Winnall WR; Parsons MS; Ananworanich J; Cooper DA; Kelleher AD; Hsu D; Pett S; Stratov I; Kramski M; Kent SJ
    J Infect Dis; 2015 Feb; 211(4):529-38. PubMed ID: 25170105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy.
    Bachtel ND; Beckerle GA; Mota TM; Rougvie MM; Raposo RAS; Jones RB; Nixon DF; Apps R
    AIDS Res Hum Retroviruses; 2019 Jan; 35(1):108-111. PubMed ID: 30198299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetically Intact but Functionally Impaired HIV-1 Env Glycoproteins in the T-Cell Reservoir.
    de Verneuil A; Migraine J; Mammano F; Molina JM; Gallien S; Mouquet H; Hance AJ; Clavel F; Dutrieux J
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.
    Misra A; Gleeson E; Wang W; Ye C; Zhou P; Kimata JT
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The thrombocytic link in hemostasis and the immunity system of patients with HIV infection].
    Poliakova AM; Kravchenko AV; Astrina OS; Serebrovskaia LV; Khabarova VV; Iurin OG; Pokrovskiĭ VV; Maleev VV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (3):80-2. PubMed ID: 7660708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-Mediated CD4 Depletion Induces Homeostatic CD4
    Kumar NA; McBrien JB; Carnathan DG; Mavigner M; Mattingly C; White ER; Viviano F; Bosinger SE; Chahroudi A; Silvestri G; Paiardini M; Vanderford TH
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of viral load and immune complex load on CD4+ lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients.
    Daniel V; Süsal C; Melk A; Weimer R; Kröpelin M; Zimmermann R; Huth-Kühne A; Uhle C; Opelz G
    Immunol Lett; 1999 Aug; 69(2):283-9. PubMed ID: 10482364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.
    Madhavi V; Kulkarni A; Shete A; Lee WS; Mclean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ;
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):345-353. PubMed ID: 28346319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection.
    Yue FY; Cohen JC; Ho M; Rahman AKMN; Liu J; Mujib S; Saiyed A; Hundal S; Khozin A; Bonner P; Liu D; Benko E; Kovacs C; Ostrowski M
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelets from HIV-infected individuals on antiretroviral drug therapy with poor CD4
    Real F; Capron C; Sennepin A; Arrigucci R; Zhu A; Sannier G; Zheng J; Xu L; Massé JM; Greffe S; Cazabat M; Donoso M; Delobel P; Izopet J; Eugenin E; Gennaro ML; Rouveix E; Cramer Bordé E; Bomsel M
    Sci Transl Med; 2020 Mar; 12(535):. PubMed ID: 32188724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection.
    Nkambule BB; Davison G; Ipp H
    Platelets; 2015; 26(3):250-7. PubMed ID: 24831969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
    Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
    J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelets and HIV-1 infection: old and new aspects.
    Torre D; Pugliese A
    Curr HIV Res; 2008 Sep; 6(5):411-8. PubMed ID: 18855651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Combination Antiretroviral Therapy Limits HIV-1 Persistence in Children.
    Luzuriaga K
    Annu Rev Med; 2016; 67():201-13. PubMed ID: 26768239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer.
    Rose R; Lamers SL; Nolan DJ; Maidji E; Faria NR; Pybus OG; Dollar JJ; Maruniak SA; McAvoy AC; Salemi M; Stoddart CA; Singer EJ; McGrath MS
    J Virol; 2016 Oct; 90(20):8984-93. PubMed ID: 27466425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.